-
Understanding NEJM in 2 minutes: the effectiveness of ALVAC-gp120 HIV vaccine
Time of Update: 2021-04-19
[Editor's note] NEJM Quick Take introduces an article of the latest NEJM in 2 minutes in the form of animation
-
To improve non-alcoholic steatohepatitis, semaglutide phase 2 trial published NEJM
Time of Update: 2021-04-19
Overall, this trial showed that compared with placebo, semaglutide treatment can significantly more patients with NASH disappeared at the histopathological level, but showed no significant difference between groups in improving the staging of liver fibrosis.
-
Positive Phase 2 Clinical Results of Telomerase Modulator for Treatment of Alzheimer's Disease Released
Time of Update: 2021-04-19
Reference materials:[1] GemVax's highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal.
-
Meta analysis of the kidney protection of new hypoglycemic drugs, SGLT-2 inhibitors are worthy of attention
Time of Update: 2021-04-19
Recently, a scholar published an article in J Clin Endocrinol Metab, and conducted a systematic review and meta-analysis of the kidney-protecting effects of three new hypoglycemic drugs based on existing clinical data.
-
Fuhong Henlius plans to submit a listing application for phase 2 clinical trial of anti-PD-1 antibody reaching the primary endpoint
Time of Update: 2021-04-19
The primary endpoint reached this time is a single-arm, open, multiple-arm, open-ended, multiple-arm, open-ended, multiple-arm, unresectable or metastatic MSI-H or dMMR solid tumor patient who has failed standard treatments to evaluate the efficacy, safety, and tolerability of HLX10.
-
Gilead's first TROP-2 target drug Trodelvy enters EU review
Time of Update: 2021-04-19
), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2), which progresses rapidly and has a very poor prognosis, 5 years The survival rate is less than 15%. TNBC is ineffective against hormone therapy and HER2
-
Both pictures and texts, teach you how to treat "hemorrhoids" under endoscopy (2)
Time of Update: 2021-04-19
It is reported in the literature that oral fiber laxatives have a good therapeutic effect on patients with hemorrhoids, which can relieve hemorrhoid symptoms and reduce bleeding.
-
Xinjiang’s “2+4” Drug Purchasing Alliance Came to Promote Inter-provincial Centralized Procurement
Time of Update: 2021-04-18
The pace is accelerating, and another inter-provincial alliance brings a lot of purchases Xinjiang "2+4
-
Gilead's Trop-2 antibody conjugate drug gains second indication
Time of Update: 2021-04-18
S. FDA has accelerated the approval of its Trop-2 antibody conjugate drug Trodelvy (sacituzumab govitecan-hziy) to expand its scope of use for the treatment of locally advanced or metastatic urothelium Cancer patients.
-
The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Time of Update: 2021-04-18
Introduction: Enzymes that play a major role in cancer and type 2 diabetes can also activate the "clear" protein in Parkinson's disease.
-
IDH1/2 inhibitor Ivosidenib/Enasidenib combined with intensive chemotherapy is well tolerated in newly treated AML patients
Time of Update: 2021-04-18
Research methods The study included newly-treated AML patients aged ≥18 years, ECOG score 0-2, and IDH1/2 mutations, who received 500mg/day Ivosidenib/Enasidenib combined with cytarabine (200mg/m2/day, total 7 Day) and daunorubicin (60mg/m2/day for 3 days) induction therapy.
-
Express | Gilead's Trop-2 antibody-conjugated drug gains second indication for the treatment of bladder cancer
Time of Update: 2021-04-18
S. FDA has accelerated its approval of its Trop-2 antibody conjugate drug Trodelvy (sacituzumab govitecan-hziy) to expand the scope of use for local treatment Patients with advanced or metastatic urothelial cancer.
-
Kelun Class 1 new drug hits 2 billion injections, the first four major products that have been reviewed and will be approved
Time of Update: 2021-04-18
hospitals, county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal alanine Acylglutamine injection exceeds 2 billion yuan. This product
-
and Monitoring Information of Food Safety Supervision in 2021 (Phase 2)
Time of Update: 2021-04-17
1. 7 batches of beverages, the inspection items are acesulfame potassium, benzoic acid and its sodium salt (calculated as benzoic acid), coliforms, protein, carbon dioxide gas capacity
-
Sci Adv: The "three brothers" of Parkinson's disease, cancer, and type 2 diabetes are originally in the same line
Time of Update: 2021-04-17
called Parkin is eager to protect mitochondria, which are power plants that generate energy for cells. Recently, Salk researchers discovered a direct connection
-
16 new cases were confirmed on April 11, and 2 local cases were in Yunnan
Time of Update: 2021-04-17
on April 11, 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps reported 16 new confirmed cases, including 14 imported cases (4 in Fujian, 3 in Shanghai, 3 in Guangdong, Shaanxi) 2 cases, 1 case
-
Yangquan Market Supervision Administration Announcement on Food Safety Supervision Sampling Inspection Information in 2021 (Phase 2)
Time of Update: 2021-04-17
html" class="zdbq" title="Food information related to national food safety standards" target="_blank">national food safety standards : 65 batches of qualified samples and 1 batch of unqualified samples were foodmate.
-
Linyi City Market Supervision Administration Announcement on Food Safety Supervision and Sampling Inspection Information in the First Quarter (2)
Time of Update: 2021-04-17
html" class="zdbq" title="Meat related food information" target="_blank">meat products , foodmate.
html" class="zdbq" title="Meat related food information" target="_blank">meat products , foodmate.
-
How to deal with the California variant of SARS-CoV-2?
Time of Update: 2021-04-16
The results of the study also showed that the L452R mutation of SARS-CoV-2 reduced the neutralizing activity of the plasma of vaccinators and convalescent donors.
-
5 points, 2 charts, quickly master the 2020 American Gastroenterological Association Guideline for Moderate-Severe Ulcerative Colitis
Time of Update: 2021-04-14
Only for medical professionals to read
